Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat

PLoS Pathogens

Volumn 11, Issue 12, 2015, Pages

  Filkins, Laura M ^a   O’Toole, George A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

BURKHOLDERIA; CYSTIC FIBROSIS; DISEASE COURSE; DISEASE TRANSMISSION; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE RESPONSE; LUNG CLEARANCE; LUNG INFECTION; MICROBIAL COMMUNITY; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PSEUDOMONAS AERUGINOSA; REVIEW; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; COINFECTION; COMPLICATION; RESPIRATORY TRACT INFECTIONS;

ANTI-BACTERIAL AGENTS; COINFECTION; CYSTIC FIBROSIS; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 84953283376     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005258     Document Type: Review

References (30)

1. Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, et al. (2003) Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 41: 3548–3558. 12904354
2. Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, et al. (2014) The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. J Cyst Fibros 13: 49–55. doi: 10.1016/j.jcf.2013.06.004 23891398
3. Madan JC, Koestler DC, Stanton BA, Davidson L, Moulton LA, et al. (2012) Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 3:e00251.
4. Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, et al. (2014) Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome 2: 40. doi: 10.1186/2049-2618-2-40 25408892
5. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, et al. (2012) Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A 109: 5809–5814. doi: 10.1073/pnas.1120577109 22451929
6. Dodge JA, Lewis PA, Stanton M, Wilsher J, (2007) Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J 29: 522–526. 17182652
7. van der Gast CJ, Walker AW, Stressmann FA, Rogers GB, Scott P, et al. (2011) Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J 5: 780–791. doi: 10.1038/ismej.2010.175 21151003
8. Gilligan PH, (2014) Infections in patients with cystic fibrosis: diagnostic microbiology update. Clin Lab Med 34: 197–217. doi: 10.1016/j.cll.2014.02.001 24856524
9. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, et al. (2008) Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog 4: e1000184. doi: 10.1371/journal.ppat.1000184 18949036
10. Frickmann H, Jungblut S, Hirche TO, Gross U, Kuhns M, et al. (2012) Spectrum of viral infections in patients with cystic fibrosis. Eur J Microbiol Immunol (Bp) 2: 161–175.
11. Wat D, Gelder C, Hibbitts S, Cafferty F, Bowler I, et al. (2008) The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 7: 320–328. doi: 10.1016/j.jcf.2007.12.002 18255355
12. Chotirmall SH, O'Donoghue E, Bennett K, Gunaratnam C, O'Neill SJ, et al. (2010) Sputum Candida albicans presages FEV(1) decline and hospital-treated exacerbations in cystic fibrosis. Chest 138: 1186–1195. doi: 10.1378/chest.09-2996 20472859
13. Filkins LM, Hampton TH, Gifford AH, Gross MJ, Hogan DA, et al. (2012) Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194: 4709–4717. doi: 10.1128/JB.00566-12 22753064
14. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, et al. (2008) A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A 105: 15070–15075. doi: 10.1073/pnas.0804326105 18812504
15. Boucher RC, (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 23: 146–158. 14738247
16. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, et al. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109: 317–325. 11827991
17. Brown PS, Pope CE, Marsh RL, Qin X, McNamara S, et al. (2014) Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. Ann Am Thorac Soc 11: 1049–1055. doi: 10.1513/AnnalsATS.201311-383OC 25072206
18. Alvarez-Ortega C, Harwood CS, (2007) Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol Microbiol 65: 153–165. 17581126
19. Schobert M, Jahn D, (2010) Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. Int J Med Microbiol 300: 549–556. doi: 10.1016/j.ijmm.2010.08.007 20951638
20. Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, et al. (2011) Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 66: 579–584. doi: 10.1136/thx.2010.137281 21270069
21. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, et al. (2006) Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 44: 2601–2604. 16825392
22. Beck JM, Young VB, Huffnagle GB, (2012) The microbiome of the lung. Transl Res 160: 258–266. doi: 10.1016/j.trsl.2012.02.005 22683412
23. Hampton TH, Green DM, Cutting GR, Morrison HG, Sogin ML, et al. (2014) The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome 2: 14. doi: 10.1186/2049-2618-2-14 25071935
24. Daniels TW, Rogers GB, Stressmann FA, van der Gast CJ, Bruce KD, et al. (2013) Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis. J Cyst Fibros 12: 22–28. doi: 10.1016/j.jcf.2012.05.008 22717533
25. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, et al. (2010) Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS ONE 5: e11044. doi: 10.1371/journal.pone.0011044 20585638
26. Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, et al. (2013) Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 10: 179–187. doi: 10.1513/AnnalsATS.201211-107OC 23802813
27. Twomey KB, Alston M, An SQ, O'Connell OJ, McCarthy Y, et al. (2013) Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation. PLoS ONE 8: e82432. doi: 10.1371/journal.pone.0082432 24358183
28. Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A, (2013) Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax 68: 1157–1162. doi: 10.1136/thoraxjnl-2013-203204 23704228
29. Kreindler JL, Steele C, Nguyen N, Chan YR, Pilewski JM, et al. (2010) Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest 120: 3242–3254. doi: 10.1172/JCI42388 20714107
30. Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL, (2003) Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 123: 1495–1502. 12740266